Company profile
Aerovance company profile
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovant™, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aeroderm™, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.
Business identity
- Website
- http://www.aerovance.com
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Founded
- 2004-01-01
Headquarters
- Headquarters
- Salem, South Dakota, United States
- Postal code
- 94710
- Country code
- US
- Continent
- North America